Document Detail

Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.
MedLine Citation:
PMID:  12865376     Owner:  NLM     Status:  MEDLINE    
CONTEXT: Cardiac troponin T (cTnT) and C-reactive protein (CRP) are prognostic markers in acute coronary syndromes. However, for patients with end-stage renal disease (ESRD) the ability of combinations of these markers to predict outcomes, and their association with cardiac pathology, are unclear.
OBJECTIVE: To investigate the association between levels of cTnT and CRP and long-term risk of cardiac pathology and death in patients with ESRD.
DESIGN, SETTING, AND PARTICIPANTS: A prospective cohort study initiated February through June 1998 and enrolling 224 patients with ESRD from 5 hemodialysis centers in the Houston-Galveston region of Texas. Levels of cTnT and CRP were analyzed at study entry in patients without ischemic symptoms.
MAIN OUTCOME MEASURES: All-cause mortality during a mean follow-up of 827 (range, 29-1327) days. Secondary outcomes in predefined substudies were coronary artery disease (CAD), decreased (< or =40%) left ventricular ejection fraction (LVEF), and presence of left ventricular hypertrophy (LVH).
RESULTS: One hundred seventeen (52%) patients died during follow-up. For levels of cTnT and CRP, progressively higher levels predicted increased risk of death compared with the lowest quartile (for cTnT quartile 2: unadjusted hazard ratio [HR], 2.2; 95% confidence interval [CI], 1.2-4.1; quartile 3: HR, 2.7; 95% CI, 1.5-4.9; quartile 4: HR, 3.0; 95% CI, 1.6-5.3. For CRP quartile 2: HR, 0.9; 95% CI, 0.5-1.6; quartile 3: HR, 1.8; 95% CI, 1.1-3.1; quartile 4: HR, 1.8; 95% CI, 1.1-3.2). Both cTnT and CRP remained independent predictors of death after adjusting for a number of potential confounders. The combination of cTnT and CRP results provided prognostic information when patients were divided into groups at or above and below the biomarker medians (high cTnT/high CRP levels vs low cTnT/low CRP levels for risk of death: HR, 2.5; 95% CI, 1.5-4.0). Elevated levels of cTnT, but not CRP, were strongly associated with diffuse CAD (n = 67; 0%, 25%, 50%, and 62% prevalence of multivessel CAD across progressive cTnT quartiles, P<.001). An LVEF of 40% or less was identified in 4 (9%), 3 (8%), 10 (27%), and 7 (19%) of patients across cTnT quartiles (P =.07). No trend for cTnT levels was found among patients with LVH (P =.45); similarly, no trend for CRP was found among patients with LVH (P =.65) or an LVEF of 40% or less (P =.75).
CONCLUSIONS: Among stable patients with ESRD, increasing levels of cTnT and CRP are associated with increased risk of death. Furthermore, higher levels of cTnT may identify patients with severe angiographic coronary disease.
Christopher deFilippi; Steven Wasserman; Salvatore Rosanio; Eric Tiblier; Heidi Sperger; Monica Tocchi; Robert Christenson; Barry Uretsky; Mathew Smiley; Judith Gold; Henry Muniz; John Badalamenti; Charles Herzog; William Henrich
Related Documents :
12095976 - Presence of the human leukocyte antigen class ii gene drb1*1101 predicts interferon gam...
12539066 - Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous ...
17702656 - Psychoneuroendocrine stress response may impair neutrophil function in complex regional...
14595706 - Langerhans cell histiocytosis patients have hla cw7 and dr4 types associated with speci...
23099306 - Early onset multiple sclerosis: a review for nurse practitioners.
15251796 - Some characteristics of primary hyperparathyroidism in vietnamese immigrants living in ...
Publication Detail:
Type:  Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  JAMA     Volume:  290     ISSN:  1538-3598     ISO Abbreviation:  JAMA     Publication Date:  2003 Jul 
Date Detail:
Created Date:  2003-07-16     Completed Date:  2003-07-18     Revised Date:  2014-09-17    
Medline Journal Info:
Nlm Unique ID:  7501160     Medline TA:  JAMA     Country:  United States    
Other Details:
Languages:  eng     Pagination:  353-9     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Markers / blood
C-Reactive Protein / metabolism*
Cardiomyopathies / blood*,  complications,  epidemiology*
Cause of Death
Cohort Studies
Coronary Angiography
Coronary Artery Disease / blood*,  complications,  epidemiology*
Hypertrophy, Left Ventricular / blood,  complications,  epidemiology
Kidney Failure, Chronic / blood*,  complications,  mortality*,  therapy
Middle Aged
Proportional Hazards Models
Prospective Studies
Renal Dialysis*
Risk Assessment
Survival Analysis
Troponin T / blood*
Ventricular Dysfunction, Left / blood,  complications,  epidemiology
Reg. No./Substance:
0/Biological Markers; 0/Troponin T; 9007-41-4/C-Reactive Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of behavioral training with or without pelvic floor electrical stimulation on stress incontin...
Next Document:  Problematic variation in local institutional review of a multicenter genetic epidemiology study.